Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 29,286 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke. DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
What this blog is for:
My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
Sunday, June 30, 2024
Hyperbaric Oxygen Post Established Stroke
I can't see any use for HBOT unless it's delivered in the first week and there are vastly easier options for delivering oxygen than that.
oxygen delivery (29 posts to January 2020) Many ideas in here, if your doctor isn't already using them to save neurons immediately post stroke; you don't have a functioning stroke doctor!
Hyperbaric Oxygen Post Established Stroke
David W. Harrison • Penny M. Brasher • Janice J. Eng • Devin Harris • Alison M. Hoens • Afshin Khazei • Jennifer K. Yao • Riyad B. Abu-Laban
Published: June 28, 2024
DOI: 10.7759/cureus.63395
Cite this article as: Harrison D W, Brasher P M, Eng J J, et al. (June 28, 2024) Hyperbaric Oxygen Post Established Stroke. Cureus 16(6): e63395. doi:10.7759/cureus.63395
Abstract
Background and purpose: Hyperbaric oxygen therapy (HBOT) has been reported to improve neurological function in the chronic phase of stroke in a single trial having significant limitations, including a lack of a sham control.
Methods: We conducted a single-center, parallel-group, randomized trial to determine the effectiveness of HBOT compared with a sham control in adults who were 6 to 36 months post-ischemic stroke. The treatment group received 40 sessions of HBOT at the Vancouver General Hospital Hyperbaric Unit. The control group received 40 sessions of sham treatment designed to replicate an HBOT experience.
Due to recruitment challenges and timeline/feasibility tracking by the research team, the control arm was altered after 20 months to a waitlist in the hope of increasing participation. In the second phase, participants were randomized to receive HBOT immediately or following an eight-week observation period.
The primary outcome was the post-treatment Stroke Impact Scale-16 (SIS-16). Secondary outcomes included the National Institute of Health Stroke Scale, Berg Balance Test, Digit Symbol Substitution Test, 5-Metre Walk Test, 6-Minute Walk Test, Grip Strength, Montreal Cognitive Assessment, Box/Block Test, and Center for Epidemiological Studies - Depression and Short Form-36. Based on detecting a clinically important between-group difference of 10 on the SIS-16 score, our target sample size was 68 participants per arm.
Results: From January 5, 2016 to October 9, 2018, 34 participants were enrolled in the trial, 27 during the first phase and seven in the second phase. The study was stopped after 36 months, and prior to meeting the sample size target, due to low recruitment. At the end of treatment, the difference in the SIS-16 between groups was 5.5 (95% CI: 1.3 to 9.7, p = 0.01) in favor of the sham group.
Conclusions: Our results exclude a clinically important benefit of HBOT on the primary outcome of the SIS-16. These findings do not support the use of HBOT in chronic stroke survivors.
Introduction
Stroke is a major cause of mortality and long-term disability. The lifetime risk of stroke is approximately 25% [1]. Over half of stroke victims have some disability at one year [2]. Furthermore, stroke accounts for over 4% of all direct healthcare costs in high-income countries [3]. The estimated annual stroke-related cost of healthcare, lost wages, and decreased productivity in Canada is approximately $3.6 billion [4].
Most of the neurological improvement among stroke survivors occurs in the first 30 to 90 days [5]. Further modest functional improvements are possible after this period with interventions from an interdisciplinary rehabilitation team, but major disability often persists [2]. Hyperbaric oxygen therapy (HBOT) has been advocated and used by some healthcare providers as a therapy to improve disability post-stroke. HBOT involves the administration of inhaled 100% oxygen at increased ambient pressure inside a closed vessel, producing greatly elevated arterial and tissue oxygen tensions, and a wide variety of physiological effects at the cellular and sub-cellular levels [6,7].
HBOT has been studied as a treatment in the acute/subacute phase and chronic (3-6 months post-stroke) phase of stroke. A 2014 Cochrane systematic review of HBOT for acute ischemic stroke found that "there was no good evidence to show that HBOT improves clinical outcomes when applied during acute presentation of ischemic stroke", although the possibility of clinical benefit had not been excluded [8].
The use of HBOT in chronic stroke has been less studied. A PubMed search for randomized controlled trials of HBOT in chronic stroke (Hyperbaric Oxygenation/ AND (Stroke Rehabilitation/ OR Stroke/) AND randomized controlled trial.pt.) published between 1960 and 2024 identified one publication. There were significant limitations with the trial: it used a waitlist control, which can lead to overestimates of treatment effects [9,10], and the validity of the primary outcome, NIHSS, is uncertain in chronic stroke [11].
In an attempt to more definitively evaluate the use of HBOT as a treatment in the chronic phase of ischemic stroke, we designed a randomized clinical trial comparing the effect of sham HBOT and true HBOT on the neurological status of participants who were between six months and three years post-stroke. We hypothesized that a course of 40 treatments of HBOT would improve neurological function, as reflected in Stroke Impact Scale-16 (SIS-16) scores.
Effects of Thermal Stimulation and Transcutaneous Electrical Nerve Stimulation on Sensory and Motor Function of Upper Extremity in Acute Stroke Survivors: A Randomized Controlled Pilot Study
Didn't your competent doctor start using thermal stimulation on you a long time ago? I guess not! So you don't have a functioning stroke doctor? Why are you seeing them?
thermal stimulation (9 posts to August 2010, my very first blog post)
Effects of Thermal Stimulation and Transcutaneous Electrical Nerve Stimulation on Sensory and Motor Function of Upper Extremity in Acute Stroke Survivors: A Randomized Controlled Pilot Study
Hong-Chi Wang • Willy Chou • Yu-Lin You • Yu-Lin Wang • Min Hsu • Chia-Chi Yang • Chen-Wen Yen • Lan-Yuen Gou
Published: June 28, 2024DOI: 10.7759/cureus.6337
Cite this article as: Wang H, Chou W, You Y, et al. (June 28, 2024) Effects of Thermal Stimulation and Transcutaneous Electrical Nerve Stimulation on Sensory and Motor Function of Upper Extremity in Acute Stroke Survivors: A Randomized Controlled Pilot Study. Cureus 16(6): e63375. doi:10.7759/cureus.63375
Abstract
Objective
Upper-limb coordination is crucial for daily activities, especially among stroke survivors who may encounter obstacles during upper-limb rehabilitation. This study aimed to investigate the effects of thermal stimulation (TS) and transcutaneous electrical nerve stimulation (TENS) on sensory and motor function during recovery in acute stroke patients.
Design
This is a parallel study with a randomized controlled design. The experiment was conducted in the E-Da Hospital Rehabilitation Department, Kaohsiung, Taiwan.
Intervention
Thirty participants were in-patients with acute stroke at the E-Da Hospital. Participants were randomly assigned to three groups for a one-week intervention: exercise combined with TS, exercise combined with TENS, or conventional physical therapy with exercise alone. The Fugl-Meyer upper extremity scale, Brunnstrom stage, minimal current perception (MCP), and modified Ashworth scale were collected for the assessment.
Results
The outcomes demonstrated considerable improvement in MCP in all the groups after treatment. Specifically, the groups receiving TS and TENS showed significant improvements in the Brunnstrom stage, suggesting that both treatments improved distal motor recovery.
Conclusion
The results, following a one-week intervention period, suggested that both TS and TENS contributed to the improvement of motor and sensory function, with a significant impact on the Brunnstrom stage in the upper extremity, particularly in the distal region. The inclusion of TS or TENS in rehabilitation protocols improved distal motor function compared to baseline measures, suggesting these treatments as effective components in acute stroke rehabilitation.
Introduction
More than 85% of post-stroke patients experience impaired upper limb functionality on the hemiplegic side [1]. In general, 55%-75% of the sequelae remain even three to six months later [2]. Furthermore, coordination of both sides of the upper extremity is needed to accomplish most daily activities such as face washing, tooth brushing, eating, and getting dressed [1]. Therefore, assisting individuals with stroke in recovering the use of their affected upper limbs was a crucial goal for rehabilitation.
Recently, sensory stimulation has often been applied simultaneously with motor stimulation in stroke-affected limbs. Sensory stimulation techniques, such as transcutaneous electrical nerve stimulation (TENS) [3-8] and thermal stimulation (TS) [9-11] have demonstrated more favorable effects on motor recovery or pain relief than motor training alone for post-stroke survivors. TENS intervention on the lower extremity demonstrated significant positive effects on the decrease in the hyperactivity stretch reflex, maximal voluntary contraction of the ankle dorsiflexor [12], and walking speed [13] in individuals with chronic stroke. Furthermore, the effects of combining TENS with task-oriented interventions showed significantly greater improvement in motor function and spasticity compared to task-oriented interventions alone for individuals with chronic stroke [5]. Hence, TENS interventions for chronic stroke may positively affect motor recovery or spasticity. On the other hand, TS, which is a sensory stimulation intervention, is usually used with hot and cold packs wrapped in the target region, and TS intervention demonstrated a significant increase in motor function and Brunnstrom stage for individuals with acute stroke [11], subacute stroke [14], and chronic stroke [15].
A possible explanation for the effectiveness of TS on sensory and motor function improvements might be that, during the acute phase of stroke, the cerebral cortex undergoes regrouping [16,17]. This constitutes a timely opportunity for the application of high levels of sensory stimulation to the affected limbs for the activation of specific cortical areas, thereby improving sensory and motor functions and alleviating secondary injuries caused by the loss of those functions [18]. Hence, the application of sensory stimulation to improve motor function in patients with stroke should be addressed in the rehabilitation protocol. Clinically, both TENS and TS are easily used and applied as rehabilitation approaches, and both interventions facilitate motor function restoration owing to the stimulation of peripheral sensory receptors and further cause excitation of the cortex [15]. Thus, investigations on the effects of TS, TENS, and conventional therapy on motor recovery of the upper extremities are essential to provide evidence for therapists to choose rehabilitation approaches and protocols. However, few studies have used sensory stimulation accompanied by motor training in stroke patients during the acute phase to determine their effects. Thus, the present study aimed to investigate the effects of TENS and TS combined with motor training on sensory and motor recovery in the upper extremities of patients with acute stroke. This study hypothesized that sensory stimulation might improve sensory and motor functions in individuals with acute stroke.
Materials & Methods
Trial design
This is a parallel study design; patients with acute stroke were assigned to the TS group, TENS group, or control group using a random number drawing method by the investigator. Assessment of sensory and motor recovery of the upper limb was performed the day before and the day after the intervention. The assessments were performed by the investigator, while the intervention was performed by two physiotherapists familiar with the research procedures. The study protocol was approved by the institutional review board of E-Da Hospital (approval number EMRP-103-113) and was registered on the ISRCTN registry (no. ISRCTN62945682). This study is a non-blinding design. One experienced physical therapist performed the intervention and the evaluation for all participants. The experiment was conducted in E-Da Hospital, Kaohsiung, Taiwan.
Participants
The sample size of this study was evaluated by power analysis using G*Power Ver.3.1.9.2 (Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany). The power analysis results revealed that a minimum sample size of 25 participants was required in this study with a significance level of 0.05, and statistical power of 0.8 for an analysis of covariance (ANCOVA) design.
Thirty participants were randomly assigned to one of three groups (n = 10 each): the TS, TENS, and control groups. The participants were inpatients with stroke at the E-Da Hospital. Patients who (1) were aged 20 years or older; (2) had a stroke for the first time and exhibited hemiparesis; (3) were hospitalized during the acute phase; (4) did not have obvious cognitive impairments; (5) could independently maintain a sitting posture for at least 30 min; and (6) had provided written informed consent for participation in this study were included. Patients were excluded if they (1) had skin conditions or injuries (e.g., wounds) on their upper limbs or had other contraindications for electrotherapy or TS (e.g., a malignant tumor); (2) had a language disorder (e.g., aphasia) and were therefore unable to communicate or comply with instructions; (3) had other orthopedic conditions (e.g., severe arthritis) or nerve damage (e.g., peripheral nerve injury) affecting movement in their upper limbs; (4) had diabetes or complete sensory impairment not caused by stroke (e.g., peripheral vascular disease or neuropathy); (5) had developed neurological disorders during the experimental period or other conditions that may have affected the study results; (6) had uncontrolled hypertension, unstable angina, a history of myocardial infarction, epilepsy (except for febrile seizures) in the past three months, or a pacemaker; or (7) had participated in other rehabilitation or drug trials. One participant from both the TS and TENS groups withdrew from the study after discharge from the hospital, and one participant in the control group withdrew due to poor attendance. Thus, nine participants remained in each of the three groups (total, n=27). The experimental flowchart is shown in Figure 1.
Treatment sessions
TS Group
In the TS group, the following equipment and intervention protocol were used. The hot and cold stimulation devices used were a Firstek heating circulator water bath (B300, Firstek Corp, Taiwan) and a Firstek cooling circulator water bath (B401L, Firstek Corp, Taiwan), respectively. Each was connected to a temperature therapy pad (TP22E, Gaymer Corp, USA). For the hot and cold stimulation, the temperatures were set at 51°C and 4°C, respectively. The participants received hot and cold stimulation in 30-minute sessions administered twice daily (once in the morning and afternoon, respectively) over five days, totaling 10 sessions. In accordance with the procedure used in one study [10], participants receiving TS were instructed to sit with both hands flat on the table. Heat stimulation was applied to their healthy arm for no more than 15 minutes. A thermometer was placed on the stimulated body part to prevent frostbite or burns. The therapy pad was wrapped around the palm and wrist of the affected limb. During the session, the therapist encouraged the participants to pull their limbs from the therapy pad through active movements. They were instructed to remove their healthy hand when they began feeling discomfort or when a score of seven had been reached on a standard 10-point visual analog scale (administered by the therapist), and the time from the beginning of the session to this point was recorded. The same procedure was repeated with the participants’ affected forearm. If no adverse skin reactions occurred, heat was applied on their affected arm 10 consecutive times, separated by three minutes of rest. Cold therapy involved the same procedure and was applied alternately with heat therapy. With both heat and cold therapy, TS was applied for 15 seconds, followed by at least 30 seconds of rest. Heat and cold were applied 20 times in each session. During each session, the therapist constantly measured the skin surface temperature on the tested limb to prevent frostbite or burns.
TENS Group
Portable TENS (TRIO-310, ITO, Japan) was used for the intervention in the TENS group. The patches were adhered to the forearm. The skin was cleaned with alcohol before and after each disinfection session to reduce the possibility of increased electrical resistance. Wounds were avoided during the study. The TENS settings were as follows: pulse width, 200 µs; output frequency, 100 Hz; output time, 30 minutes. The output frequency was selected mainly for stimulating the Aβ fibers, which produce sensations of light touch and pressure [19]. The current strength was adjusted to the maximum that participants could withstand. As with TS, TENS was applied in 30-minute session administered twice daily (once in the morning and afternoon) over five days, totaling 10 sessions. Moreover, the therapist monitored the participants during each session and measured their blood pressure, heart rate, and breathing before and after the intervention, adjusting the rest periods as necessary and taking care to prevent electrical burns.
Control Group
Participants in the control group received regularly scheduled rehabilitation therapy (one hour each of physical and occupational therapy). Physical therapy includes therapeutic exercise, facilitation training, and functional training. Occupational therapy involves hand function training for activities of daily living.
Outcome measurements
Outcome measures were conducted before and after a one-week intervention. The Fugl-Meyer Upper Extremity (FMUE) scale, Brunnstrom stage classification-proximal and distal ends of the upper limb, minimal current perception (MCP), and modified Ashworth scale (MAS) for the elbow flexor and wrist flexor were used to evaluate the intervention effects.
FMUE Scale Assessment
FMUE measurements were used to evaluate motor function, sensory function, joint range of motion, and balance. An ordinal level of measurement was used. The FMUE has high reliability (intraclass correlation coefficient, ICC=0.99) for evaluating motor function after post-stroke [20].
Brunnstrom Stage Assessment
Brunnstrom stage was used to evaluate motor recovery after brain injury. There were six evaluation stages. Stage 1 is flaccid, which means that the limb does not have movement or muscle tone, while stage 6 is near normal, which means that the motor performance of the limb is near normal. The Brunnstrom stage classification had high intra- and inter-rater reliability (ICC for inter-rater=0.94, ICC for intra-rater=0.97) [21].
Minimal Current Perception
Pain vision PS-2100 (Nipro Co., Osaka, Japan) was used to evaluate sensory deficits in individuals with stroke. The electrical stimulation frequency was set at 50 Hz. Participants held a switch on the device to activate and stop the device. The weak current increased gradually when the participant switched on the device. The participant was then asked to switch off the device when they felt the current [22].
MAS Assessment
This study evaluated the spasticity of the elbow and wrist flexors using MAS. MAS is a reliable assessment tool for evaluating limb spasticity (ICC=0.86) [23]. First, the joint range of motion was measured, and the therapist manually stretched the participants to observe limb resistance.
Statistical analysis
Analyses were conducted using IBM SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY, USA). Chi-square tests were performed on categorical variables to determine the presence of between-group differences based on sex, affected side, and stroke type. Continuous demographic data and baseline measurements were evaluated using a one-way analysis of variance (ANOVA).
One-way analysis of covariance (ANCOVA) and paired t-tests were performed to determine between-group differences and significant differences between the pre-test and post-test in each group. The significance level was set at p<0.05. The Bonferroni correction was used for post-hoc comparisons.
Results
The three groups showed no significant differences in the demographic data and baseline outcome measurements (Table 1). Significant differences after the intervention compared to baseline measurements were found in the FMUE for all groups (TS group, 95% CI: -10.00, -7.34, p<0.01; TENS group, 95% CI: -8.15 and -5.40, p<0.01; control group, 95%CI: -7.77 and -3.34, p<0.01) (Figure 2A). In addition, a significant difference between the TS and control groups was observed in the FMUE (p=0.02) (Figure 2A). The comparisons of the differences of pre- and post-test were significant in MCP for all groups (TS group, 95%CI:2.48 and 14.92, p=0.02; TENS group, 95% CI:1.37 and 7.81, p=0.01; control group, 95% CI:1.15 and 7.78, p=0.01) (Figure 2B). However, there were no significant differences among the groups at the post-test in the MCP test.
TS group (n=9) | TENS group (n=9) | Control group (n=9) | P-value | |
Age (years) | 65 (9.2) | 64.9 (7.3) | 67.7(5.7) | 0.68b |
Number of Gender (Male / Female) | 6/3 | 6/3 | 4/5 | 0.54a |
Number of affected side (Left/Right) | 5/4 | 5/4 | 4/5 | 0.86a |
Number of types of stroke (Ischemia/Hemorrhagic) | 7/2 | 8/1 | 8/1 | 0.75a |
Fugl-Meyer Upper Extremity Scale (Scores) | 11.2(9.9) | 11.6(12.2) | 11.1(13) | 0.89b |
Minimal current perception (μA) | 31.6(14.5) | 33.1(17.9) | 26.7(14) | 0.65b |
Modified Ashworth scale_Elbow flexor (scores) | 0.1(0.3) | 0.2(0.4) | 0.1(0.3) | 0.75b |
Modified Ashworth scale_Wrist flexor (scores) | 0.1(0.3) | 0.4(0.5) | 0.2(0.4) | 0.27b |
Brunnstorm stage Proximal end of upper limb (Scores) | 2.3(0.7) | 2.3(1.0) | 2.4(1.0) | 0.94b |
Brunnstrom stage_Distal end of upper limb (Scores) | 2.3(1.0) | 2.3(0.9) | 2.6(1.1) | 0.74b |
Table 1: Comparison of demography in study groups
Figure 2: (A) Fugl-Meyer Upper Extremity (FMUE) scale and (B) minimal current perception (MCP) data comparison between pre-test and post-test.
Significant differences were found in the FMUE for all groups compared to baseline measurements (TS group, 95% CI: -10.00, -7.34, p<0.01; TENS group, 95% CI: -8.15 and -5.40, p<0.01; control group, 95%CI: -7.77 and -3.34, p<0.01), with a significant difference observed between the TS and control groups (p=0.02). Additionally, significant differences in MCP were found in all groups comparing pre- and post-test values (TS group, 95%CI: 2.48 and 14.92, p=0.02; TENS group, 95% CI: 1.37 and 7.81, p=0.01; control group, 95% CI: 1.15 and 7.78, p=0.01) (Figures 2A, 2B). However, no significant differences among the groups were observed in the post-test in the MCP test.
Significant differences after the intervention compared to the baseline measurements were not found in the MAS of the elbow flexors for all groups (Figure 3A) or the wrist flexors for all groups (Figure 3B). There were no significant differences among the groups at post-test in the MAS scores of the elbow flexors and wrist flexors (Figures 3A, 3B).
Figure 3: Modified Ashworth Scale (MAS) of (A) elbow flexor and (B) wrist flexor comparison between pre-test and post-test.
Significant differences after the intervention compared to baseline measurements were found in the Brunnstrom stage classification of the proximal end for all groups (TS group, p<0.01; TENS group, p<0.01; control group, p=0.02) (Figure 4A). However, there was no significant difference among the groups in the Brunnstrom stage classification of the proximal end at the post-test (Figure 4A). Significant differences after the intervention compared to the baseline measurements were found in the Brunnstrom stage classification of the distal end for the TS group (p=0.02) and the TENS group (p=0.04) (Figure 4B); however, there was no significant difference between the pre-test and post-test in the Brunnstrom stage classification of the distal end for the control group. There was no significant difference among the groups in the Brunnstrom stage classification of the distal end at the post-test (Figure 4B).
Discussion
In the current study, TS and TENS interventions were applied for one week to evaluate their effects on the recovery of motor and sensory functions in the upper limbs of acute stroke patients. Significant improvements in FMUE scores were observed in all three groups after the intervention, with the TS group showing superior performance compared to the control group. Short-term improvements in motor function, with no differences in spasticity in the elbow and wrist flexors, were seen in all groups according to MCP results. The proximal end of the Brunnstrom stage showed significant short-term improvements in all groups, while the distal end showed immediate improvement only in the experimental group after one week. These results suggest the efficacy of TS and TENS in improving short-term motor recovery in acute stroke patients. Additionally, the study highlighted the significant effects of the TS intervention on FMUE, supporting its role as a sensory stimulation tool in restoring motor function during stroke recovery. Previous research has further supported the positive effects of TS on motor recovery in acute and subacute stroke patients, as observed on the Action Research Arm Test and the upper extremity subscale of the Stroke Rehabilitation Assessment of Movement [9,11]. TS and TENS have shown promise in managing acute stroke patients. Previous research has shown that repetitive sensory stimulation and mass motor practice could promote neuroplasticity and cortical reorganization in stroke patients, which might contribute to improved motor function [6]. There was also evidence indicating that TENS had demonstrated positive outcomes in alleviating brain damage following ischemic stroke by reducing oxidative stress, inhibiting neuronal pyroptosis, and activating mitophagy pathways [24]. Therefore, both TS and TENS, either individually or in combination, could be valuable adjuncts to conventional therapy in enhancing motor recovery and functional outcomes in acute stroke patients.
With our understanding, this study was the first to compare the recovery of motor and sensory functions in the upper limbs of individuals with acute stroke by simultaneously applying TS and TENS, common modalities in clinical rehabilitation [6,24]. Several studies have suggested the benefits of both TS and TENS for motor recovery in acute stroke patients. However, most of these studies had focused on either one modality or a combination with other interventions, such as TENS with taping [25]. Nevertheless, there has been little research comparing the efficacy of TS and TENS concurrently for upper limb motor recovery in individuals with acute stroke.
Between-group comparisons revealed that the TS group demonstrated more substantial post-intervention improvements in terms of the FMUE scores than the control group. In contrast, the TENS group did not significantly outperform the control group. Notably, all three groups exhibited significant improvements in the FMUE scores in the post-test, with the TS group outperforming the control group. The higher performance of the TS group on the FMUE scores compared to the other groups might be due to several factors. First, many of the items assessed in the FMUE were related to distal hand and wrist control, which correlated with improvements in the distal Brunnstrom stage. Another possible reason might have been the active participation in the thermal and cold stimulation procedure, which involved moving the hand back and forth, which was believed to enhance proprioceptive input, leading to improved motor control in the affected upper limb movements [26]. This suggests that motor learning potentially boosts proprioception and body movements by influencing the relationship between somatosensory and motor systems through neural pathways. This active participation likely contributed to the improvement in FMUE scores. In contrast, the TENS group largely maintained a static posture during the intervention, resulting in no significant difference in FMUE improvement compared to the control group.
The TENS group also exhibited significant improvements after the intervention, but these changes were not significant compared with the control group. This result does not support the premise that the motor improvements observed in the TENS group were attributable to the intervention. The previous study involved individuals in the chronic phase of stroke who received a combination of upper extremity TENS and task-related training (30 minutes per day, five days per week, four weeks). This intervention resulted in significant improvements in a variety of assessments, including the FMUE, the Manual Functional Test, the Box and Block Test, and the MAS. Specifically, the group that received TENS in addition to task-oriented training showed significant improvement, particularly in reducing spasticity according to the MAS. In contrast, the control group, which received placebo TENS and task-oriented training, did not show similar improvement. The researchers concluded that the improved motor function was primarily due to motor training effects and highlighted the effectiveness of TENS in reducing spasticity [27]. In the present study, the spasticity scores on the MAS of 0.2±0.4 indicated low tension, which is understandable given that the participants were all in the acute phase. This also explains why the effects of TENS were less apparent.
Overall, all three groups demonstrated improvements in motor function after the intervention. This may be associated with the fact that the participants were in the acute phase when brain reorganization was the most active. Although this result was only observed in the FMUE group, significant post-intervention differences were only present between the TS and control groups. Less substantial differences were noted between the TENS and control groups; however, based on the mean value, the TENS group improved more than the control group. Moreover, the proximal and distal parts of the Brunnstrom stage indicated that both TS and TENS resulted in greater improvement. Therefore, it could be suggested that additional interventions using TS or TENS could potentially aid in the recovery of upper limb motor function in individuals with acute stroke. This research was in line with findings from previous studies, which suggested that TS and TENS activated the cortical areas responsible for motor function [5,28].
Regarding the assessment of sensory function, the present study used devices that allowed for the quantification of perception and pain with regard to the MCP of each participant. In all three groups, the postintervention MCP differed significantly from the preintervention MCP; however, no significant between-group differences were observed. A study reported that individuals with stroke (three months after stroke occurrence) who received intermittent pneumatic compression (30-min sessions, five days a week, four weeks) with conventional rehabilitation treatments outperformed the control group, who only received conventional rehabilitation treatments on the Nottingham Sensory Assessment Scale, two-point discrimination test, and tactile and joint kinesthesia assessments, despite both groups demonstrating significant post-intervention improvements [29]. In a similar study, the experimental and control groups underwent TS (sessions of 20-30 min, five days a week, six weeks) and conventional rehabilitation, respectively. Both groups had significant post-intervention improvements in the Semmes-Weinstein monofilament test, with the experimental group outperforming the control group [11]. These collective results suggest that interventions during the acute phase of stroke can lead to considerable improvements in the recovery of sensory function regardless of the use of additional sensory inputs. Moreover, sensory stimulation appears to exert more substantial benefits on sensory recovery than conventional rehabilitation. Furthermore, although significant improvements were observed among all three groups after the intervention, no significant between-group differences were detected. This might be because the intervention lasted only one week, which was considerably shorter than that in previous studies (at least four weeks).
In the present study, the MAS measurements of the elbow and wrist flexors did not change significantly after the intervention in any group. A previous study applied TENS to the upper limbs of individuals with stroke (on average, 12 months post-stroke). The intervention comprised 30-min sessions administered five times a week over four weeks, and similarly, the stroke individuals exhibited a significant reduction in muscle tension after the intervention [5]. The following arguments regarding the mechanism by which TENS reduces post-stroke spasticity have been proposed. First, TENS can promote the release of the inhibitory neurotransmitter gamma-aminobutyric acid in the posterior gray column [30]. Second, spasticity is caused by hyperexcitability of the central nervous system. The application of TENS to the surrounding nerves can lower spasticity through reciprocal inhibition [5]. In the present study, no changes in spasticity or significant differences were observed among the three groups after the intervention. This may be because the intervention period of five days was not sufficient to induce a significant reduction in spasticity.
Study limitations
There were some limitations in interpreting the results of this study. First, the intervention period of this study was only five days; hence, it may not be sufficient to improve spasticity. Second, the sample size was relatively small; there were only nine participants with acute stroke in each group. Finally, this study had a non-blinded design, which may have influenced the results. Second, this study had a non-blinded design; one experienced physical therapist carried out the evaluation and intervention, while the study did not include the placebo group; hence, the participants were not blinded.
Conclusions
The use of TS in individuals with acute stroke demonstrated a significant improvement in pain perception compared to conventional physical therapy. Both TS and TENS had positive effects on motor function recovery at the distal end of the upper limb compared with baseline measurements. This study suggested that incorporating TS or TENS in the rehabilitation protocol potentially improved motor function in individuals with acute stroke, compared to those who received conventional physical therapy alone.
Time: It’s part of what makes KHSC’s acute stroke team tick
So what? You don't measure time to delivery, you measure results! How many got 100% recovered? I'd have you all fired for not knowing what the objective is in stroke. 100% RECOVERY! NOT time!
Time: It’s part of what makes KHSC’s acute stroke team tick
We’re kind of a big deal.
The last time we checked, Kingston Health Sciences Centre’s Regional Stroke Centre of Southeastern Ontario was still the fastest centre - of the 11 in Ontario - to remove clots and restore blood flow to the brain with Endovascular Treatment (EVT). And we’ve been the fastest for seven straight years.
Fast, world-class treatment can result in longer lives for Kingston-area residents and the 60 per cent of patients who live elsewhere (Belleville, Bancroft, Brockville, Gananoque, Napanee, Perth, Picton, SmithsFalls, Trenton and surrounding areas) and are transported by Paramedic Services to KHSC to receive EVT.
During EVT, a small catheter is inserted into the patient’s leg and is then navigated, using special imaging equipment, into the brain to remove the clot causing the stroke. This happens in one of KHSC’s Interventional Radiology angiography suites.
Take a look at these impressive KHSC times to get from the Emergency Department door to:
- The CT scan suite: 9 minutes (provincial target is 15 mins.)
- Start of EVT: 39 minutes (provincial target is 60 mins.)
- Remove clot and restore blood flow: 57 minutes (provincial target is 90 mins.)
Every minute saved means fewer brain cells die from lack of oxygen.
“We’re the fastest treating regional stroke centre in Ontario because we rely on and trust everyone to take charge on their turf without hesitation,” says stroke neurologist Dr. Al Jin.
Last year, KHSC completed 100 EVT cases, that’s up 11 per cent from the previous year. It’s also a huge jump from the 10 cases completed in 2016 when KHSC first began providing the treatment.
Stroke rehabilitation: From diagnosis to therapy
You're completely missing the complete failure of everything in stroke!
0. There is no fast, easy and objective way to diagnose a stroke.
1. tPA may save your life with tPA having a 88% failure rate for full recovery.
2. Your neurologist doesn't have any concrete stroke protocols to stop the neuronal cascade of death in the first week, thus saving millions to billions of neurons!
3. Your neurologist or physiatrist doesn't have any clue about how to get you to full recovery. (Ask them exactly how to do it), you'll get excuses.
4. Only 10% get to full recovery..
5. No protocols to prevent your 33% dementia chance post-stroke from an Australian study.
6. Nothing to alleviate your fatigue.
7. Nothing that will cure your spasticity.
8. Nothing on cognitive training unless you find this yourself.
9. No published stroke protocols.
10. No way to compare your stroke hospital results vs. other stroke hospitals.
Everything in stroke is a complete failure.
Stroke rehabilitation: From diagnosis to therapy
- 1 First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
- 2 Tehran University of Medical Sciences, Tehran, Tehran, Iran
The final, formatted version of the article will be published soon.
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Stroke remains a significant global health burden, necessitating comprehensive and innovative approaches in rehabilitation to optimize recovery outcomes. This paper provides a thorough exploration of rehabilitation strategies in stroke management, focusing on diagnostic methods, acute management, and diverse modalities encompassing physical, occupational, speech, and cognitive therapies. Emphasizing the importance of early identification of rehabilitation needs and leveraging technological advancements, including neurostimulation techniques and assistive technologies, this manuscript highlights the challenges and opportunities in stroke rehabilitation.Additionally, it discusses future directions, such as personalized rehabilitation approaches, neuroplasticity concepts, and advancements in assistive technologies, which hold promise in reshaping the landscape of stroke rehabilitation. By delineating these multifaceted aspects, this manuscript aims to provide insights and directions for optimizing stroke rehabilitation practices and enhancing the quality of life for stroke survivors.
Keywords: Stroke, Rehabilitation, neuroplasticity, neurostimulation, motor learning
Received: 22 Mar 2024; Accepted: 28 Jun 2024.
Copyright: © 2024 Li, He, Wang and Rezaei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Evidence-based physiotherapeutic concepts for improving arm and hand function in stroke patients
Ask your competent? doctor if in the ensuing 22 years we've gone from 'improving' to delivering recovery. If not, WHY THE FUCK HAVEN'T WE GOTTEN THERE?
Evidence-based physiotherapeutic concepts for improving arm and hand function in stroke patients
Abstract
Barwon Health’s Stroke Unit achieves international recognition
This means ABSOLUTELY NOTHING! 100% recovery is the only measurement needed and they aren't even doing that! You don't measure 'care' that tells you nothing!
If you don't measure 100% recovery, you'll never get there. Words have meaning and 'care' is not what survivors want to hear. 'Care' is passive, not action oriented.
“What's measured, improves.” So said management legend and author Peter F. Drucker
Barwon Health’s Stroke Unit achieves international recognition
BARWON Health’s Stroke Unit has been internationally recognised for the quality of its treatment and care (NOT RECOVERY!)with World Stroke Organization (WSO) Angels platinum status.
The award operates on a tiered system – gold, platinum, diamond – and celebrates high-performing hospitals that consistently demonstrate a clear commitment to quality stroke care(NOT RECOVERY!), with established systems in place to support continuous improvement.
Presented quarterly, the award benchmarks across several indicators, with much of the criteria focused on the speed at which patients in hospitals begin receiving treatment in emergency settings.
Barwon Health stroke co-ordinator Michelle Hiddleston said the team, based at University Hospital Geelong, had been working hard to enhance its processes and deliver better outcomes to its patients, the success of which had ultimately led to the award.
“The biggest thing we’re proud of is our collaboration as a team – it involves Ambulance Victoria, Emergency Department, medical imaging and stroke team.
“It’s definitely not a one-person show. We’re able to achieve this because of the hard work our emergency services do every day and also the amazing team that we have on the stroke unit.”
Ms Hiddleston said reaching these indicators, which include delivering hyperacute treatments to 100 per cent of patients within 60 minutes and treating a high percentage of patients within a dedicated stroke unit, had a significant impact on the stroke patients treated at the hospital.
“1.9 million brain cells die per minute before someone’s treated in a
stroke and that means that rapid treatment improves patient outcomes –
there’s strong evidence for that. (But you're not measuring recovery, measuring time to treatment is totally wrong! You don't measure the process, you measure the results! If I did that in my programming career I'd be fired in no time!)
“The quicker that we can reperfuse that blood vessel that’s being blocked, the better the outcome(But you don't tell us the outcome! Is it 100% recovery or not?) for the patient and [the lesser the] risk of permanent damage and disability.”
The award now places Barwon Health’s Stroke Unit among a very small group of Australian healthcare providers to have achieved the same status.
“Being a regional centre, we don’t want to be [at] any disadvantage compared to metropolitan [centres],” Ms Hiddleston said.
“It’s about making sure that we are benchmarking with bigger services in Melbourne and making sure that the care(NOT RECOVERY!) that we’re providing our stroke patients is the same care(NOT RECOVERY!) that they would receive up in metropolitan centres.”
She said receiving the WSO Angels platinum status had further motivated the team, increasing the standard of care(NOT RECOVERY!) the unit expects from itself.
“The platinum award has motivated the team to keep striving to reach these benchmarks and making sure that we’re continually treating patients quickly and we’re providing them with stroke unit care(NOT RECOVERY!), where possible.
“Our standards are quite high now and we strive to win many awards moving forward.”(Well, they are not the right standards to be measuring, You measure 100% recovery which is what survivors want!)